Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

Under this BAA BARDA is soliciting proposals for the advanced R&D of MCM for CBRN agents; the ever-present and ever -evolving threat of pandemic influenza; and the re-emergence and emergence of infectious diseases.

Research Areas of Interest:

1. CBRN Vaccines

2. CBRN Antivirals and Antitoxins

3. Antimicrobials

4. Radiological/Nuclear Threat Medical Countermeasures

5. Chemical Threat Medical Countermeasures

6. Burn and Blast Medical Countermeasures

7. Diagnostics

8. Influenza and Emerging Infectious Diseases (IEID) Vaccines

9. Influenza and Emerging Infectious Diseases (IEID) Therapeutics

10. Immunichip+

11. COVID-19 Immune Assay(s) Development and Implementation

12. Flexible and Strategic Therapeutics (FASTX)

Funding: No fixed limit

Duration: 5 years

Research Authority due date: 10 days prior to submission 

Stage 1 Pre submission call

Stage 2 upon request Abstract

Full proposal upon request. BAA closes on 28.9.2028